Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:bimatoprost
|
| gptkbp:administeredBy |
topical application
|
| gptkbp:approvalYear |
2008
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
S01EE03
|
| gptkbp:brand |
gptkb:bimatoprost
|
| gptkbp:contraindication |
allergy to bimatoprost
eye infection |
| gptkbp:form |
gptkb:government_agency
eye drops |
| https://www.w3.org/2000/01/rdf-schema#label |
Latisse
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Allergan
|
| gptkbp:marketedIn |
gptkb:Canada
gptkb:United_States |
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:relatedTo |
glaucoma medications
|
| gptkbp:routeOfAdministration |
topical
|
| gptkbp:sideEffect |
eye redness
darkening of eyelid skin increased brown pigmentation of the iris itchy eyes |
| gptkbp:usedFor |
eyelash growth
|
| gptkbp:bfsParent |
gptkb:Allergan
|
| gptkbp:bfsLayer |
6
|